|
Name |
avertoxin B
|
Molecular Formula | C28H36O9 | |
IUPAC Name* |
methyl4-[2-[6-(2-ethyl-3,4-dihydroxy-3,3a-dimethyl-2,4,5,6a-tetrahydrofuro[2,3-b]furan-5-yl)hexa-1,3,5-trienyl]-3-methyl-6-oxopyran-4-yl]oxy-2-methylbut-2-enoate
|
|
SMILES |
CCC1OC2OC(C=CC=CC=Cc3oc(=O)cc(OCC=C(C)C(=O)OC)c3C)C(O)C2(C)C1(C)O
|
|
InChI |
InChI=1S/C28H36O9/c1-7-22-28(5,32)27(4)24(30)20(36-26(27)37-22)13-11-9-8-10-12-19-18(3)21(16-23(29)35-19)34-15-14-17(2)25(31)33-6/h8-14,16,20,22,24,26,30,32H,7,15H2,1-6H3/b9-8+,12-10+,13-11+,17-14+/t20-,22-,24+,26+,27+,28+/m1/s1
|
|
InChIKey |
SVAOKUCSYGOWSM-KJQUAOOJSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 516.59 | ALogp: | 3.2 |
HBD: | 2 | HBA: | 9 |
Rotatable Bonds: | 9 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 124.7 | Aromatic Rings: | 3 |
Heavy Atoms: | 37 | QED Weighted: | 0.285 |
Caco-2 Permeability: | -4.827 | MDCK Permeability: | 0.00001450 |
Pgp-inhibitor: | 0.994 | Pgp-substrate: | 0.731 |
Human Intestinal Absorption (HIA): | 0.1 | 20% Bioavailability (F20%): | 0.634 |
30% Bioavailability (F30%): | 0.989 |
Blood-Brain-Barrier Penetration (BBB): | 0.749 | Plasma Protein Binding (PPB): | 85.28% |
Volume Distribution (VD): | 1.331 | Fu: | 13.50% |
CYP1A2-inhibitor: | 0.025 | CYP1A2-substrate: | 0.212 |
CYP2C19-inhibitor: | 0.041 | CYP2C19-substrate: | 0.608 |
CYP2C9-inhibitor: | 0.06 | CYP2C9-substrate: | 0.05 |
CYP2D6-inhibitor: | 0.011 | CYP2D6-substrate: | 0.302 |
CYP3A4-inhibitor: | 0.499 | CYP3A4-substrate: | 0.706 |
Clearance (CL): | 9.79 | Half-life (T1/2): | 0.49 |
hERG Blockers: | 0.622 | Human Hepatotoxicity (H-HT): | 0.882 |
Drug-inuced Liver Injury (DILI): | 0.4 | AMES Toxicity: | 0.355 |
Rat Oral Acute Toxicity: | 0.755 | Maximum Recommended Daily Dose: | 0.964 |
Skin Sensitization: | 0.425 | Carcinogencity: | 0.952 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.006 |
Respiratory Toxicity: | 0.905 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005399 | 0.848 | D0FG6M | 0.255 | ||||
ENC001850 | 0.760 | D0B1IP | 0.239 | ||||
ENC003443 | 0.569 | D0E9KA | 0.236 | ||||
ENC005401 | 0.511 | D05QDC | 0.231 | ||||
ENC005764 | 0.452 | D0Q0PR | 0.229 | ||||
ENC005994 | 0.433 | D0H2MO | 0.202 | ||||
ENC003144 | 0.433 | D0L5FY | 0.195 | ||||
ENC005765 | 0.419 | D06BLQ | 0.191 | ||||
ENC003161 | 0.264 | D0S7WX | 0.188 | ||||
ENC002117 | 0.264 | D02YIZ | 0.188 |